Suppression of interleukin-6 production in macrophages by furonaphthoquinone NFD-37

International Immunopharmacology

Volumn 6, Issue 6, 2006, Pages 916-923

  Shin, Hyun Mo ^a   Lee, Yong Rok ^b   Chang, Yoon Sook ^a   Lee, Jun Young ^a   Kim, Byung Hak ^a   Min, Kyung Rak ^a   Kim, Youngsoo ^a  

^a Chungbuk National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Furonaphthoquinone; IL 6 production; Macrophages; NF B activation

Indexed keywords

2 METHYL 2 (2 METHYLPROPENYL) 2,3 DIHYDRONAPHTHOQUINONE[2,3 B]FURAN 4,9 DIONE; FURONAPHTHOQUINONE; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NFD 37; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPRESSION VECTOR; GENE ACTIVITY; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; GENE EXPRESSION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; NAPHTHOQUINONES; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 33646102439     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.006     Document Type: Article

References (35)

1. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149 (2003) 1-38
2. Barton B.E. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 85 (1997) 16-20
3. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51 (2000) 245-270
4. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16 (1998) 249-284
5. Wong P.K., Campbell I.K., Egan P.J., Ernst M., and Wicks I.P. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 48 (2003) 1177-1189
6. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332 (1988) 83-85
7. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
8. Miyake K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin Immunol 16 (2004) 11-16
9. Palsson-McDermott E.M., and O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113 (2004) 153-162
10. Baeuerle P.A., and Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242 (1988) 540-546
11. Andreakos E., Sacre S.M., Smith C., Lundberg A., Kiriakidis S., Stonehouse T., et al. Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103 (2004) 2229-2237
12. Ye H., Arron J.R., Lamothe B., Cirilli M., Kobayashi T., Shevde N.K., et al. Distinct molecular mechanism for initiating TRAF6 signaling. Nature 418 (2002) 443-447
13. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18 (2000) 621-663
14. Magnani M., Crinelli R., Bianchi M., and Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-κB (NF-κB). Curr Drug Targets 1 (2000) 387-399
15. Tian B., and Brasier A.R. Identification of a nuclear factor κB-dependent gene network. Recent Prog Horm Res 58 (2003) 95-130
16. Kim B.H., Cho S.M., Reddy A.M., Kim Y.S., Min K.R., and Kim Y. Down-regulatory effect of quercitrin gallate on nuclear factor-κB-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. Biochem Pharmacol 69 (2005) 1577-1583
17. Park M.H., Song H.S., Kim K.H., Son D.J., Lee S.H., Yoon do Y., et al. Cobrotoxin inhibits NF-κB activation and target gene expression through reaction with NF-κB signal molecules. Biochemistry 44 (2005) 8326-8336
18. Min K.R., Lee H., Kim B.H., Chung E.Y., Cho S.M., and Kim Y. Inhibitory effect of 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide on nitric oxide and interleukin-6 production in macrophages. Life Sci 77 (2005) 3242-3257
19. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
20. Hirai K.I., Koyama J., Pan J., Simamura E., Shimada H., Yamori T., et al. Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells. Cancer Detect Prev 23 (1999) 539-550
21. Nagata K., Hirai K.I., Koyama J., Wada Y., and Tamura T. Antimicrobial activity of novel furanonaphthoquinone analogs. Antimicrob Agents Chemother 42 (1998) 700-702
22. Takegami T., Simamura E., Hirai K., and Koyama J. Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus. Antiviral Res 37 (1998) 37-45
23. Lee Y.R., Suk J.Y., and Kim B.S. One-pot construction of medium- and large-sized ring substituted furans: efficient conversion to dibenzofurans, coumestans, and 4-pyrones. Org Lett 2 (2000) 1387-1389
24. Lee J.H., Koo T.H., Hwang B.Y., and Lee J. Kaurane diterpene, kamebakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-κB target genes. J Biol Chem 277 (2002) 18411-18420
25. Moon K.Y., Hahn B.S., Lee J., and Kim Y.S. A cell-based assay system for monitoring NF-κB activity in human HaCat transfectant cells. Anal Biochem 292 (2001) 17-21
26. Gao H., Parkin S., Johnson P.F., and Schwartz R.C. C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters. J Biol Chem 277 (2002) 38827-38837
27. Shin H.M., Kim M.H., Kim B.H., Jung S.H., Kim Y.S., Park H.J., et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation. FEBS Lett 571 (2004) 50-54
28. Smolinski A.T., and Pestka J.J. Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver. J Inflamm 2 (2005) 6-13
29. Sanceau J., Kaisho T., Hirano T., and Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NF-κB, and Sp1 transcription factors. J Biol Chem 270 (1995) 27920-27931
30. Hehner S.P., Hofmann T.G., Droge W., and Schmitz M. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J Immunol 163 (1999) 5617-5623
31. Garcia-Pineres A.J., Lindenmeyer M.T., and Merfort I. Role of cysteine residues of p65/NF-κB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. Life Sci 75 (2004) 841-856
32. Hungness E.S., Pritts T.A., Luo G.J., Sun X., Penner C.G., and Hasselgren P. The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1β-stimulated human enterocytes. Shock 14 (2000) 386-391
33. Hershko D.D., Robb B.W., Luo G., and Hasselgren P. Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 283 (2002) R1140-R1148
34. Yin M.J., Yamamoto Y., and Gaynor R. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396 (1998) 77-80
35. 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins. Blood 105 (2005) 1750-1758